Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
41 /100
MEDIUM RISK
Score updated Aug 28, 2026

RGC — Regencell Bioscience Holdings Limited Dilution Risk Tracker

Track RGC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RGC — Get alerts when the score changes →

As of August 28, 2026, Regencell Bioscience Holdings Limited (RGC) has a DilutionWatch DilutionScore of 41/100, rated MEDIUM dilution risk. Regencell Bioscience Holdings Limited has a market capitalization of $11.82B, 494.49M shares outstanding, 35 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
67
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for RGC.
🔔 Track RGC — Get forecast alerts →

Market Data

Market Cap$11.82B
Shares Outstanding494.49M
Float55.41M
Cash$8.89M
Debt$3.00M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 32.8% shares (2026Q1 vs prior)
35 institutional holders · 878.0K shares
#1 GEODE CAPITAL MANAGEMENT, LLC 415.6K shares
#2 MORGAN STANLEY 79.3K shares
#3 SUSQUEHANNA INTERNATIONAL GROUP, LLP 72.7K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest903.0K
Days to Cover4.0
% of Float1.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2022-06-30
Full SEC filing analysis available with free account

Recent News

No recent news

Factual RGC Dilution Snapshot

Regencell Bioscience Holdings Limited (RGC) has a DilutionScore of 41/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track RGC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RGC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for RGC
RGC FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.